INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
SKIN
SUSTAINABILITY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
MEDIA PACK
CONTRIBUTE
Subscribe
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
SKIN
SUSTAINABILITY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
MEDIA PACK
CONTRIBUTE
SEARCH
SEARCH
advanced search
INDUSTRIALISATION
INJECTION
Dr Uwe Rothhaar
SCHOTT Pharma
PACKAGING MATERIAL IDENTIFICATION TO ENSURE SELECTION OF BEST-MATCHING COMPONENTS FOR PARENTERAL DRUGS
Uwe Rothhaar, Daniel Haines, Matthias Bicker and Thomas Schmidt discuss the analytical techniques used to identify the material components and composition of primary containers for injectable drug products.
INJECTION
Olivia Houselander
Owen Mumford
THE CHALLENGES OF DEVELOPING DRUG DELIVERY DEVICES FOR THE JAPANESE MARKET
Olivia Houselander outlines some of the challenges of developing drug delivery devices for the Japanese market and shares details of Owen Mumford’s latest two products to gain approval in Japan.
INJECTION
Manuela Giacon
Stevanato Group
DELIVERING ON GLP-1 DEMAND: A COMBINATION OF DEVICE OFFERINGS AND SUPPLY STRATEGY
Manuela Giacon and Josh Gordon, review the growth in demand for glucagon-like peptide-1 treatments and present Stevanato Group's response to this exciting opportunity, showcasing its Alina
®
device platform for pen injectors and the Aidaptus
®
two-step, single-use autoinjector.
INJECTION
Vetter Pharma
COMPANY SHOWCASE: VETTER PHARMA
Vetter is a CDMO that offers services for pharma and biotech firms of all sizes and locations and holds numerous patents, including technologies for protection against tampering and counterfeiting. Its expertise ranges from lyophilisation (freeze-drying) to siliconisation and more.
INJECTION
Jeff Clement
PCI Pharma Services
ACCELERATING INNOVATION: THE POWER OF PARALLEL DEVELOPMENT FOR AN AUTOINJECTOR LAUNCH
Jeff Clement and Bill Welch explore the essential considerations for navigating the parallel development of a drug product in a vial and a prefilled syringe for an autoinjector, together with the downstream final assembly and pack considerations, from early-phase clinical trials to commercialisation.
EXPERT VIEW
Dan Cowen
ACCELERATING COMBINATION PRODUCT DEVELOPMENT USING DIGITAL TWIN TECHNOLOGY
Dan Cowen, Sebastian White and Anthony Robinson, discuss the value that implementing a digital twin could provide to drug delivery device design across multiple stages of a development programme.
INJECTION
Dr Michael Adler
ten23 health
TRANSITIONING FROM VIAL TO SUBCUTANEOUS INJECTION DEVICES FOR BIOLOGICAL DRUG PRODUCTS
Michael Adler, Venkata Appa Reddy Goli, Andrea Allmendinger and Hanns-Christian Mahler, discuss the various factors that need to be considered when transferring to a delivery device for subcutaneous injection, such as a prefilled syringe or autoinjector, during clinical trials or post-launch, especially when transferring from a vial format for intravenous infusion.
EXPERT VIEW
Dr Timothy Noakes
NAVIGATING THE TRANSITION TO SUSTAINABLE MEDICAL PROPELLANTS
Timothy Noakes, Sheryl Johnson and Richard Greenhough, discuss the status of the current move from high-global-warming-potential propellants for pressurised metered dose inhalers to more sustainable alternatives.
SUSTAINABILITY
Alissa Monk
ten23 health
LEVERAGING AI & BIG DATA FOR ECO-DESIGN COLLABORATION IN PHARMA
Alissa Monk, Kami Krista, Cédric Montagnetegy and Carole Schanté, explore the potential of artificial intelligence and big data in eco-design with the aim of transforming the pharmaceutical industry towards greater sustainability.
INDUSTRIALISATION
Marcus Jarman-Smith
Victrex
ADVANCING PHARMACEUTICAL CONTACT APPLICATIONS WITH PEEK: MEETING INCREASING DEMANDS
Marcus Jarman-Smith and Yann Tréguier, discuss the myriad benefits that Victrex’s pharmaceutical-grade PEEK can offer to the drug delivery sector as a material of construction due to its versatile material properties.
INDUSTRIALISATION
Dr Alan Watts
Catalent Pharma Solutions
ARCUS
®
: A COMMERCIALISED TECHNOLOGY ENABLING HIGH-DOSE, HIGHLY RESPIRABLE POWDERS
Alan Watts and Michael Tauber, discuss the requirements and benefits of using spray-dried powders for inhalation, and how ARCUS, used for the successfully commercialised Inbrija® dry powder inhaler, is a prime example of this technology in action.
RESPIRATORY
Gemma Budd
Aptar Pharma
ADVANCING OINDP CLINICAL TRIALS WITH SPEED AND EFFICIENCY: STRATEGIES FOR SUCCESS
Gemma Budd and Julie Suman, consider the key issues that preclinical and clinical trials for orally inhaled and nasal drug products must address within the context of the information that regulators are looking for, providing insight, strategies and advice for both novel and generic products in this sector.
INTERVIEW
Dr Sandy Munro
Phillips Medisize
Interview with Sandy Munro, Vectura
In this exclusive interview with ONdrugDelivery’s Guy Furness, Sandy Munro, PhD, of Vectura discusses his extensive career, focused on respiratory drug delivery. He shares his insights into current trends within the industry, including the growth of biologics, systemic delivery via inhalation, the potential of mesh nebulisers and connectivity in clinical trials.
OCULAR
Dr Andrea Allmendinger
ten23 health
ADDRESSING INTRAVITREAL PRODUCT MANUFACTURING AND DEVELOPMENT CHALLENGES
Andrea Allmendinger, Hanns-Christian Mahler and Philipp Behrendt discuss the challenges of filling very small volumes into syringes for intravitreal injections, and how ten23’s innovative filling technology can help combat the critical issue of air bubble formation.
INJECTION
Peter Schmidt
ZwickRoell
FAST, STANDARD-COMPLIANT AND COST-EFFICIENT TESTING OF PREFILLED SYRINGES FOR OPTIMAL RESULTS
Peter Schmidt presents ZwickRoell’s solutions for testing autoinjectors and wearables to ensure a systematic increase in productivity in the testing lab.
INTERVIEW
Dr Alexandre Fontayne
Unither Pharmaceuticals
Interview with Alexandre Fontayne, Unither Pharmaceuticals
Guy Furness and Alexandre Fontayne discusses Unither Pharmaceuticals' EuroJect
®
injection device, based on the company’s extensive experience with blow-fill-seal technology. Mr Fontayne covers the advantages of EuroJect
®
compared with traditional glass syringes and multidose vials, as well as touching on where Unither sees EuroJect
®
having an impact in the market
PREFILLED SYRINGES
Shiva Douse
Celanese
SANTOPRENE
®
TPV – A NEXT STEP IN ELASTOMERIC COMPONENTS FOR CONVENTIONAL, SAFETY AND PREFILLED SYRINGES AND AUTOINJECTORS
Shiva Douse, Jeff Smith and Brad Wessman introduce Santoprene® TPV, a novel medical-grade thermoplastic elastomer for use in syringes and autoinjectors that offers significant benefits over traditional thermoset rubbers.
INJECTION
Bill Welch
PCI Pharma Services
KEY CONSIDERATIONS FOR SUCCESSFUL COMMERCIALISATION OF DRUG-DEVICE COMBINATION PRODUCTS
Bill Welch delves into the key considerations that stakeholders must address to ensure the successful commercialisation of drug-device combination products.
CONFERENCE SHOWCASE
RDD
INTERVIEW: RDD EUROPE 2023 REVIEW & RDD 2024 PREVIEW
Respiratory Drug Delivery talks with ONdrugDelivery, reviewing highlights of the successful RDD Europe 2023 event, which took place in Antibes, France last May, then describing what’s ahead for RDD 2024, which will take place in Tuscon, AZ, US, next May, including some of the key upcoming deadlines for participants.
INDUSTRIALISATION
Edwin Hendrawan
SHL Medical
AN AUTOINJECTOR REVOLUTION: ADVANCED SIMULATION TECHNOLOGIES ENHANCING GLOBAL MANUFACTURING NETWORKS
Edwin Hendrawan, Yi-Chi Lu and Christian Walter set out how SHL is building simulation capabilities, and describe how simulation will propel the business forward on every level, from individual shop floors to overall global expansion planning, in order to be able to meet the growing and increasingly complex demands from both pharma customers and patients.
INTERVIEW
Jeff Henderson
Vetter Pharma
INTERVIEW with Jeff Henderson
Jeff Henderson discusses the practice of outsourcing within the pharmaceutical industry. He considers factors that pharma and biopharma companies should consider when determining whether or not to outsource to a CDMO and many of the advantages that outsourcing can offer, especially to small- and medium-sized companies.
INTERVIEW
Claire Raynal-Olive
Aptar Pharma
Interview with Claire Raynal-Olive & Pierre-Yves Favennec
Claire Raynal-Olive and Pierre-Yves Favennec discuss the strategy and objectives of Aptar Pharma’s expansion programme of its global rubber component manufacturing, implementing advanced technology, increased capacity and local-for-local manufacturing capability.
INDUSTRIALISATION
Dr Dave Seaward
3P Innovation
AUTOMATING ASSEMBLY TO EXPEDITE TIME-TO-MARKET
Dave Seaward discusses how 3P innovation takes a holistic approach to solving the technical challenges encountered by its clients and looks for opportunities to enhance the final product, enable efficient processing and support commercially viable manufacturing.
INDUSTRIALISATION
Michele Guasti
Terumo Medical Care Solutions
TERUMO GLOBAL PARENTERAL CDMO – INTEGRATED INNOVATION
Michele Guasti discusses the advantages that Terumo’s parenteral CDMO brings to customers due to its position as a single service provider from formulation to final product and its intimate understanding of Terumo’s range of prefillable polymer syringes.
Prev
1
…
3
4
5
6
7
…
14
Next
Top
